Clinical Trials on Advanced Metastatic Melanoma in New Zealand
Total 3080 results
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Advanced MelanomaUnited States, Netherlands, Spain
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Dermatologic Cooperative Oncology GroupUnknown
-
Anaveon AGRecruitingAdvanced Solid Tumor | Metastatic Melanoma | Melanoma (Skin) | Cutaneous Melanoma | Adult DiseaseUnited States, Spain, Germany, France, Italy
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.CompletedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Exicure, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Merkel Cell Carcinoma | Advanced or Metastatic Cutaneous Squamous Cell Carcinoma | Advanced or Metastatic Melanoma | Advanced or Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Novartis PharmaceuticalsTerminated
-
Ryan StephensonRecruiting
-
Novartis PharmaceuticalsCompleted
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Bristol-Myers SquibbCompletedAdvanced MelanomaUnited States, United Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States
-
NewLink Genetics CorporationCompletedMetastatic Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
TransMolecularTerminatedMelanoma | Metastatic Melanoma | Malignant MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
VicalCompletedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbMedarexCompleted
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia